Abstract
1. The plasma propranolol concentrations after a single oral dose of 40 mg were measured in 25 patients with rheumatoid arthritis and compared with those of 16 patients with Crohn's disease from a previous study. Thirteen healthy volunteers were used as controls. 2. In both diseases some high and some low values occurred. This scatter did not correlate with any symptoms or biochemical or haematological data other than with the erythrocyte sedimentation rate (ESR). 3. Both sets of patients were therefore separated into two groups depending on whether or not their ESRs were above or below 20 mm/l h. In both diseases the plasma propranolol concentrations of the patients with a raised ESR were significantly higher than the controls as well as those of the low ESR group. 4. In rheumatoid arthritis the plasma propranolol concentrations of the patients with a low ESR did not differ from those of the controls, but in Crohn's disease they remained significantly higher. 5. In one patient with Crohn's disease there was a dramatic rise in propranolol concentrations during an exacerbation (ESR 91 mm/l h) compared with those during a remission (ESR 20 mm/l h). 6. A difference in smoking habits did not seem to have been responsible for the difference in plasma propranolol concentrations.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Babb J., Bishop H., Schneider R. E., Hawkins C. F., Hoare A. M. Letter: Plasma-propranolol levels in inflammation disease. Lancet. 1976 Jun 26;1(7974):1413–1413. doi: 10.1016/s0140-6736(76)93065-8. [DOI] [PubMed] [Google Scholar]
- Castleden C. M., George C. F., Short M. D. Contribution of individual differences in gastric emptying to variability in plasma propranolol concentrations. Br J Clin Pharmacol. 1978 Feb;5(2):121–122. doi: 10.1111/j.1365-2125.1978.tb01610.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cooper B. T., Cooke W. T., Lucas M. L., Blair J. A. Propranolol absorption in Crohn's disease and coeliac disease. Br Med J. 1976 Nov 6;2(6044):1135–1135. doi: 10.1136/bmj.2.6044.1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lucas M. L., Blair J. A., Cooper B. T., Cooke W. T. Relationship of the acid micro-climate in rat and human intestine to malabsorption. Biochem Soc Trans. 1976;4(1):154–156. doi: 10.1042/bst0040154. [DOI] [PubMed] [Google Scholar]
- SCHANKER L. S., TOCCO D. J., BRODIE B. B., HOGBEN C. A. Absorption of drugs from the rat small intestine. J Pharmacol Exp Ther. 1958 May;123(1):81–88. [PubMed] [Google Scholar]
- Schneider R. E., Babb J., Bishop H., Mitchard M., Hoare A. M. Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. Br Med J. 1976 Oct 2;2(6039):794–795. doi: 10.1136/bmj.2.6039.794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shand D. G., Nuckolls E. M., Oates J. A. Plasma propranolol levels in adults with observations in four children. Clin Pharmacol Ther. 1970 Jan-Feb;11(1):112–120. doi: 10.1002/cpt1970111112. [DOI] [PubMed] [Google Scholar]
- Shand D. G., Rangno R. E. The disposition of propranolol. I. Elimination during oral absorption in man. Pharmacology. 1972;7(3):159–168. doi: 10.1159/000136285. [DOI] [PubMed] [Google Scholar]
- Vaughan D. P., Beckett A. H., Robbie D. S. The influence of smoking on the intersubject variation in pentazocine elimination. Br J Clin Pharmacol. 1976 Apr;3(2):279–283. doi: 10.1111/j.1365-2125.1976.tb00604.x. [DOI] [PMC free article] [PubMed] [Google Scholar]